KLHL8 Activators are a diverse set of chemical compounds that indirectly stimulate the functional activity of KLHL8 through modulation of various signaling pathways. Compounds such as Forskolin, Isoproterenol, IBMX, and Dibutyryl-cAMP (db-cAMP) all act to increase intracellular levels of cAMP, which in turn activates PKA. The activation of PKA is known to lead to the phosphorylation of proteins, and this post-translational modification could directly enhance the functional activity of KLHL8. Similarly, Epigallocatechin gallate (EGCG) serves as a kinase inhibitor that may affect the activity of KLHL8 by attenuating the activity of kinases that would normally compete with or negatively regulate KLHL8, thereby indirectly potentiating its function in the cell. Additionally, modulators of intracellular calcium levels, such as Ionomycin and A23187 (Calcimycin), by increasing calcium concentration within the cell, can activate calmodulin-dependent pathways that have the potential to indirectly enhance the activity of KLHL8 via calcium-dependent phosphorylation events.
Furtherregulating the cellular signaling landscape, Phorbol 12-myristate 13-acetate (PMA) and Spermine serve as activators of protein kinase C (PKC) and modulators of ion channels, respectively. PMA's activation of PKC can lead to a cascade of phosphorylation events that may impinge upon KLHL8's phosphorylation state, thereby enhancing its activity. Spermine, through its impact on ionic balance and channel function, could lead to an altered cellular signaling environment that favors the activation of KLHL8. On the other hand, LY294002 and U0126, as inhibitors of PI3K and MEK respectively, might cause a shift in cellular equilibrium that indirectly upregulates KLHL8 activity by modifying the signaling pathways that impinge on its function. Similarly, the inhibition of p38 MAPK by SB203580 might create a cellular context conducive to the enhanced activity of KLHL8 by modulating stress and inflammation signaling pathways in which KLHL8 could play a role. Collectively, these KLHL8 activators, through their targeted biochemical actions, contribute to the enhancement of the functional activity of KLHL8 by influencing the signaling pathways and cellular processes that are crucial for its regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing levels of cyclic AMP (cAMP) in cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate KLHL8, potentially leading to its enhanced functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a potent antioxidant that inhibits several protein kinases. By modulating kinase activity, EGCG could indirectly enhance the functional activity of KLHL8 by influencing the signaling pathways that regulate its function. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium can activate calmodulin-dependent pathways, which may indirectly enhance the activation state of KLHL8 through calcium-dependent phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of downstream targets that can modify KLHL8's functional activity, potentially enhancing its role in intracellular signaling cascades. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that elevates intracellular cAMP levels, similar to forskolin. Increased cAMP can activate PKA, which may phosphorylate KLHL8 and enhance its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor that prevents the breakdown of cAMP, leading to its accumulation. This can result in the activation of PKA and possible enhancement of KLHL8 activity through PKA-mediated phosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, like ionomycin, and increases intracellular calcium levels. This can lead to the activation of calcium-dependent signaling pathways, potentially enhancing the phosphorylation and activity of KLHL8. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter AKT signaling pathways. By modulating PI3K/AKT signaling, LY294002 may indirectly affect the functional activity of KLHL8 through downstream effects on cellular signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that impacts the MAPK/ERK pathway. By altering this pathway, U0126 could lead to changes in KLHL8 activity as it may be part of signaling cascades influenced by MAPK/ERK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may modulate stress response pathways. By inhibiting p38 MAPK, SB203580 could shift signaling dynamics in a way that enhances KLHL8's activity within the cell. | ||||||